IQVIA™ Real-World Insights Bibliography

Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
Author(s): Colombo GL, Heiman F, Peduto I
Affiliations(s): Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publication(s):  Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Health economics, Overactive bladder,
2021
  L:
A:
English
Clinical setting: Primary care, Cost of illness,
  Add to report
 
 
Impact of overactive bladder symptoms on work activity: the ACTIVHA study
Author(s): Rapariz M1, Mora AM2, Roset M3.
Affiliations(s): 1, Servicio de Urología, Hospital de Gran Canaria Dr. Negrín, Gran Canaria, España 2,Astellas Pharma, Madrid, España 3, Real World Insights, QuintilesIMS, Barcelona, España
Publication(s): 
Document Type(s): 
Countries: 
C:
Y:
Overactive bladder,
2018
  L:
A:
Spanish
  Add to report
 
 
The Economic Impact of Overactive Bladder Syndrome in Six Western Countries.
Author(s): Irwin DE1, Mungapen L2, Milsom I3, Kopp Z4, Reeves P2, Kelleher C5
Affiliations(s): 1Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC, US 2 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 3 Department of Obstetrics & Gynaecology, Sahlgrenska Academy at the University of Gothenburg, Sweden 4 Pfizer Inc., New York, USA, , 5 Department of Obstetrics and Gynaecology, Guy?s and St Thomas? NHS Foundation Trust, London, UK
Publication(s):  British Journal of Urology International (BJU International), 103(2):202-209
Document Type(s): Article,
Countries: Canada, Germany, Italy, Spain, Sweden, UK,
Click here for the abstract
C:
Y:
Overactive bladder,
2009
  L:
A:
English
Budget impact,
  Add to report
 
 
The Toviaz YourWay Plan: A multidimensional program for managing overactive bladder.
Author(s): Taylor P1, Trocio J2, Schabert VF3, Golberg EL3, Bavendam T2, Brubaker L4
Affiliations(s): 1 Emory University, Atlanta, GA, USA 2 Pfizer Inc., New York, NY, USA 3 IMS Health, Inc., Falls Church, VA, USA 4 Loyola University, Maywood, IL, USA
Publication(s):  American Urogynecologic Society 30th Annual Scientific Meeting, 2009, September, Hollywood, FL, USA
Document Type(s): Oral presentation,
Countries: 
C:
Y:
Overactive bladder,
2009
  L:
A:
English
Review,
  Add to report
 
 
Challenges for managing overactive bladder and guidance for patient support.
Author(s): Schabert VF1, Bavendam T2, GoldbergEL1, Trocio JN2, Brubaker L3
Affiliations(s): 1 IMS Health, Inc., Falls Church, VA, USA 2 Pfizer, Inc., New York, NY, USA 3 Loyola University, Chicago, IL, USA
Publication(s):  American Journal of Managed Care, 2009, 15(4 Suppl): S118-122
Document Type(s): Article,
Countries: 
C:
Y:
Overactive bladder,
2009
  L:
A:
English
Survey research,
  Add to report
 
 
Dvelopment of a multidimensional approach to managing overactive bladder.
Author(s): Taylor P1, Goldberg EL2, Schabert VF2, Trocio J3, Bavendam T3
Affiliations(s): 1 Emory University, Atlanta, GA, USA 2 IMS Health, Inc., Falls Church, VA, USA 3 Pfizer Inc., New York, NY, USA
Publication(s):  American Academy of Physician Assistants 37th Annual Conference, 2009, May 23-28, San Diego, CA, USA
Document Type(s): Poster,
Countries: 
C:
Y:
Overactive bladder,
2009
  L:
A:
English
Survey research,
  Add to report
 
 
Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder.
Author(s): Pelletier EM1, Vats V2, Clemens JQ3
Affiliations(s): 1IMS Health, Watertown, MA, USA, 2Pfizer Inc., New York, NY, USA, 3University of Michigan, Ann Arbor, MI, USA
Publication(s):  American Journal of Managed Care, 2009, 15(Suppl 4): S108-S114
Document Type(s): Manuscript in preparation,
Countries: USA,
C:
Y:
Overactive bladder,
2009
  L:
A:
English
Compliance, Cost analysis,
  Add to report
 
 
Patterns and Predictors of Overactive Bladder-specific Quality of Life.
Author(s): Benner J1, Brubaker L, Bavendam T, Fanning F, Goldberg E2, Trocio J3, Jumadilova Z
Affiliations(s): 1 Formerly of IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA 3 Pfizer, New York, NY, US
Publication(s):  Journal of Pelvic Medicine & Surgery;2007 Sept/Oct;13(5):302-303(#91P)
Document Type(s): Manuscript in preparation,
Countries: USA,
C:
Y:
Overactive bladder,
2008
  L:
A:
English
Quality of life,
  Add to report
 
 
?Overactive bladder symptom bother is more prevalent in men than women at older ages.?
Author(s): Albo M, Rovner E, Mullins C, Becker R, Jumadilova Z, Benner J.
Affiliations(s): 
Publication(s):  American Urology Association Western Section Meeting, October 2006
Document Type(s): Oral presentation,
Countries: USA,
C:
Y:
Overactive bladder,
2006
  L:
A:
English
Epidemiological study,
  Add to report
 
 
?Patient-Reported Reasons for Discontinuing Overactive Bladder (OAB) Medications.?
Author(s): Brubaker L, Nichol M, Fanning T, Becker R, Jumadilova Z, Benner J
Affiliations(s): 
Publication(s):  Annual International Continence Society Meeting, November 2006.
Document Type(s): Abstract,
Countries: USA,
C:
Y:
Overactive bladder,
2006
  L:
A:
English
  Add to report
 
 
 1 of 2 Next Page Last Page